lp-a.org

Epidemiology

Phenotypic clustering splits high-Lp(a) patients into four ASCVD-risk subgroups, RED-CARPET study of 11,629 (Clin Res Cardiol 2026)

Original title: Phenomapping of subgroups in high-Lp(a) patients: a data-driven cluster analysis in RED-CARPET study

Clin Res Cardiol · · 7

Zhang S, Lin X, Zhan R, Zhou H, Lai Y, Huang M, Li B, Liao X, Zhuang X

RED-CARPET study (ChiCTR2000039901) at Sun Yat-Sen University's First Affiliated Hospital, 11,629 participants with Lp(a) measured, using k-means clustering on high-Lp(a) patients (50 mg/dL or more) to identify phenotypic subgroups and their ASCVD risk versus a low-Lp(a) reference (below 50 mg/dL). Four clusters emerged: dyslipidaemia (cluster 1), aged females (cluster 2), males with unhealthy lifestyle (cluster 3), and anaemia/renal insufficiency/hypercoagulability (cluster 4). ASCVD risk differed markedly by cluster: cluster 3 (unhealthy-lifestyle males) had the highest risk (OR 2.12, 95% CI 1.62-2.76, p<0.001), while cluster 4 showed no significant association (OR 0.82, 95% CI 0.58-1.16, p=0.233); findings were consistent after propensity score matching. The authors conclude high-Lp(a) patients can be stratified into four phenotypically distinct subgroups with markedly different ASCVD risk, supporting phenotype-guided rather than one-size-fits-all risk assessment.

Read the paper (DOI)PubMed

Original abstract

Background: The association between high levels of lipoprotein (a) [Lp(a)] and cardiovascular disease (CVD) is influenced by clinical characteristics. We aimed to explore the heterogeneity in high Lp(a) population with different clinical phenotypes and their relationship with atherosclerosis cardiovascular disease (ASCVD) risk.

Methods And Results: We included 11,629 participants with Lp(a) measurement in RED-CARPET Study (ChiCTR2000039901) from the First Affiliated Hospital of Sun Yat-Sen University. The primary outcome was the occurrence of ASCVD events. The k-means clustering method was performed for baseline variables in participants with high Lp(a) levels (Lp(a) ≥ 50 mg/dL). Multivariate logistic regression model was used to assess the association between high Lp(a) level and ASCVD across clusters, with the low-Lp(a) group (Lp(a) < 50 mg/dL) serving as reference. Propensity score matching (PSM) was used to validate thefindings. High-Lp(a) group was categorized into four clusters: cluster 1 (dyslipidemia); cluster 2 (aged females); cluster 3 (males with an unhealthy lifestyle) and cluster 4 (anemia, renal insufficiency and hypercoagulability). Patients in different clusters exhibited differences in ASCVD risk. Patients with high-Lp(a) had significantly highest risk for ASCVD in cluster 3 (OR 2.12, 95% CI 1.62-2.76, p < 0.001) after adjusting for traditional risk factors. However, no significant association was observed in cluster 4 (OR 0.82, 95% CI 0.58-1.16, p = 0.233). These findings remained consistent after PSM.

Conclusions: Using a data-driven approach, high-Lp(a) patients can be stratified into four phenotypically distinct subgroups with different ASCVD risk.

ancestryepidemiologyrisk prediction

Summary written by lp-a.org from the published abstract; figures as published. Page updated 17 August 2026. Methods.